Geode Capital Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2M Buy
5,863,654
+151,358
+3% +$843K ﹤0.01% 1873
2025
Q4
$51.2M Sell
5,712,296
-175,459
-3% -$1.09M ﹤0.01% 1462
2025
Q3
$21.8M Sell
5,887,755
-107,043
-2% -$292K ﹤0.01% 1956
2025
Q2
$11.7M Buy
5,994,798
+864,194
+17% +$1.8M ﹤0.01% 2256
2025
Q1
$9.03M Buy
5,130,604
+179,409
+4% +$408K ﹤0.01% 2353
2024
Q4
$13.2M Buy
4,951,195
+922,503
+23% +$2.38M ﹤0.01% 2188
2024
Q3
$9.23M Buy
4,028,692
+196,247
+5% +$599K ﹤0.01% 2432
2024
Q2
$11.2M Buy
3,832,445
+705,247
+23% +$2.15M ﹤0.01% 2251
2024
Q1
$11.4M Buy
3,127,198
+80,873
+3% +$155K ﹤0.01% 2254
2023
Q4
$4.6M Buy
3,046,325
+146,203
+5% +$188K ﹤0.01% 2748
2023
Q3
$3.89M Buy
2,900,122
+169,412
+6% +$282K ﹤0.01% 2768
2023
Q2
$4.92M Buy
2,730,710
+342,435
+14% +$582K ﹤0.01% 2682
2023
Q1
$3.96M Buy
2,388,275
+69,241
+3% +$140K ﹤0.01% 2737
2022
Q4
$4.45M Buy
2,319,034
+45,718
+2% +$92.5K ﹤0.01% 2725
2022
Q3
$5.09M Buy
2,273,316
+270,082
+13% +$771K ﹤0.01% 2668
2022
Q2
$6.49M Sell
2,003,234
-270,237
-12% -$1.18M ﹤0.01% 2551
2022
Q1
$12M Buy
2,273,471
+115,891
+5% +$651K ﹤0.01% 2235
2021
Q4
$18.3M Buy
2,157,580
+748,225
+53% +$6.88M ﹤0.01% 2011
2021
Q3
$14M Buy
1,409,355
+605,416
+75% +$5.49M ﹤0.01% 2211
2021
Q2
$7.48M Buy
803,939
+282,357
+54% +$3.22M ﹤0.01% 2660
2021
Q1
$5.45M Buy
+521,582
New +$5.83M ﹤0.01% 2752

Other funds holding NUVB